For clinicians/citizens

2026. 06. 24

New C2H Report: Insulin Icodec (Awiqli)

2026. 06. 24

New C2H Report: Nirmatrelvir/Ritonavir (Paxlovid)

2026. 05. 13

New C2H Report: Sacituzumab Govitecan (TRODELVY)

2019. 03. 06

International symposium - Current status and future role of HTA in Japan and other countries